These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16935384)

  • 1. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
    Tanaka Y; Mukaide M; Orito E; Yuen MF; Ito K; Kurbanov F; Sugauchi F; Asahina Y; Izumi N; Kato M; Lai CL; Ueda R; Mizokami M
    J Hepatol; 2006 Nov; 45(5):646-53. PubMed ID: 16935384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
    Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
    Shinkai N; Tanaka Y; Ito K; Mukaide M; Hasegawa I; Asahina Y; Izumi N; Yatsuhashi H; Orito E; Joh T; Mizokami M
    J Clin Microbiol; 2007 Oct; 45(10):3191-7. PubMed ID: 17652471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
    Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
    J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
    Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
    Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines.
    Sakamoto T; Tanaka Y; Orito E; Co J; Clavio J; Sugauchi F; Ito K; Ozasa A; Quino A; Ueda R; Sollano J; Mizokami M
    J Gen Virol; 2006 Jul; 87(Pt 7):1873-1882. PubMed ID: 16760389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.
    Lyu H; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ
    J Viral Hepat; 2013 Mar; 20(3):219-24. PubMed ID: 23383661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
    Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
    Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
    Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
    J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.
    Bai X; Zhu Y; Jin Y; Guo X; Qian G; Chen T; Zhang J; Wang J; Groopman JD; Gu J; Tu H
    Carcinogenesis; 2011 Jan; 32(1):63-8. PubMed ID: 20876702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma.
    Welschinger R; Kew MC; Viana R; Badri M
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):541-5. PubMed ID: 20173647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
    Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
    Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JGH Foundation emerging leadership lecture. Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia.
    Chan HL
    J Gastroenterol Hepatol; 2011 Jan; 26(1):8-12. PubMed ID: 21175787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients.
    Truong BX; Yano Y; Seo Y; Phuong TM; Tanaka Y; Kato H; Miki A; Utsumi T; Azuma T; Trach NK; Mizokami M; Hayashi Y; Kasuga M
    J Med Virol; 2007 Sep; 79(9):1293-304. PubMed ID: 17607788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
    Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.